Currently, Senti Biosciences Inc [SNTI] is trading at $10.00, up 362.96%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SNTI shares have gain 360.70% over the last week, with a monthly amount glided 360.83%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Senti Biosciences Inc [NASDAQ: SNTI] stock has seen the most recent analyst activity on October 07, 2022, when Morgan Stanley initiated its Equal-Weight rating and assigned the stock a price target of $7.50.
This stock has fluctuated between a low of $1.52 and a high of $7.43 over the last 52 weeks. Senti Biosciences Inc [NASDAQ: SNTI] shares were valued at $10.00 at the most recent close of the market.
Analyzing the SNTI fundamentals
Trailing Twelve Months sales for Senti Biosciences Inc [NASDAQ:SNTI] were 0.00M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at -12.22% with Operating Profit Margin at -190.09%, Pretax Profit Margin comes in at -212.82%, and Net Profit Margin reading is -212.9%. To continue investigating profitability, this company’s Return on Assets is posted at -1.23, Equity is -1.55 and Total Capital is -1.3.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.39 points at the first support level, and at 0.77 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.78, and for the 2nd resistance point, it is at 21.55.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Senti Biosciences Inc [NASDAQ:SNTI] is 1.92. Also, the Quick Ratio is 1.92, while the Cash Ratio stands at 1.16.
Transactions by insiders
Recent insider trading involved Omid C Farokhzad, Former Affiliate, that happened on Dec 02 ’24 when 83277.0 shares were purchased.
